A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab (NCT07504783) | Clinical Trial Compass
CompletedNot Applicable
A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab
Switzerland261 participantsStarted 2026-01-22
Plain-language summary
The aim of this study was to assess physician and patient satisfaction with ofatumumab using data collected from physicians and their multiple sclerosis (MS) patients in real-world clinical practice across the United Kingdom (UK), France, Germany, Italy, Spain, China, Japan, and Brazil.
Who can participate
Age range
18 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Physician inclusion criteria:
* Physicians must be actively involved in the treatment/management of patients with MS
* Consult with a minimum of 16 MS patients (\>5 in Japan and China, \>10 in Brazil) per month
Patient inclusion criteria:
Patients for whom physicians complete a Physician Completed Patient Record Form (PRF), and therefore are included in the pool of data for analysis, are based on the following criteria:
* Patients who had a physician-made diagnosis of MS before or at the time of data collection
* Patients must not currently be involved in a clinical trial
* Patients ≥18 years old
* For patients included in the ofatumumab sample, they must have been receiving ofatumumab for \>12 months at the time of data collection
Exclusion criteria:
• None
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number and Percentage of Patients by Patient-reported Level of Satisfaction With Current MS Treatment
Timeframe: 1 Day
2
Number and Percentage of Patients by Patient-reported MS Status With Their Current Medication Compared to Previous Medication
Timeframe: 1 Day
3
Number and Percentage of Patients by Physician-reported Patient Response to Current MS Treatment
Timeframe: 1 Day
4
Number and Percentage of Patients by Physician-reported Level of Satisfaction With the Patient's Current MS Treatment
Timeframe: 1 Day
5
Number and Percentage of Patients Adherent to Current MS Treatment as Reported by the Physician
Timeframe: 1 Day
6
Number and Percentage of Patients by Physician-reported Change in Patient Condition Since Initiation of Current MS Treatment